You are here

Article Text

Article menu

Download PDFPDF

Article
Short report
Idiopathic thrombocytopenic purpura and MMR vaccine
Free
  1. E Millera,
  2. P Waighta,
  3. C P Farringtonb,
  4. N Andrewsa,
  5. J Stowec,
  6. B Taylorc
  1. aImmunisation Division, Public Health Laboratory Service Communicable Disease Surveillance Centre, Colindale, London NW9 5EQ, UK, bDepartment of Statistics, The Open University, Milton Keynes MK7 6AA, UK, cRoyal Free Campus, Royal Free and University College Medical School, University College London, London NW3 2PF, UK
  1. Dr Millere.miller{at}phls.co.uk

Abstract

A CAUSAL ASSOCIATION BETWEEN MEASLES mumps–rubella (MMR) vaccine and idiopathic thrombocytopenic purpura (ITP) was confirmed using immunisation/hospital admission record linkage. The absolute risk within six weeks of immunisation was 1 in 22 300 doses, with two of every three cases occurring in the six week post-immunisation period being caused by MMR. Children with ITP before MMR had no vaccine associated recurrences.

  • MMR
  • vaccine
  • idiopathic thrombocytopenia purpura

http://dx.doi.org/10.1136/adc.84.3.227

Statistics from Altmetric.com

    View Full Text

    Footnotes

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      Copyright information:

      Royal College of Paediatrics and Child Health